FOS and triple-negative breast carcinoma: These targeted the folate receptor on triple-negative breast cancer cells via endocytosis and showed significant anti-tumor effects by inducing apoptosis, inhibiting proliferation, and preventing migration through targeting Activator protein 1 (AP-1) transcription factors [136,137].